Familial Breast Cancer susceptibility / Fanconi anemia, complementation group N

Definition

The PALB2 gene (FANCN) encodes a protein that binds to the BRCA2 protein and localizes it to sites of DNA double-strand break repair. In women carrying a monoallelic germline variant, the lifetime risk of breast cancer rises to ~35-40% (~12% in the general population); biallelic variants lead to Fanconi anemia complementation group N, with bone marrow failure, congenital anomalies and childhood cancer predisposition.

Gene/region examined

PALB2 - Whole Gene

Method

Sequence analysis

Accepted sample types

EDTA blood, AF, CVS

Inheritance

Hereditary; a monoallelic variant is inherited as autosomal dominant breast/pancreatic cancer susceptibility, while biallelic variants are inherited as autosomal recessive (AR) Fanconi anemia.

Related Tests